Connect with us

COVID-19

Ontario brings back mask mandates to long-term care homes

Published

5 minute read

From LifeSiteNews

By Clare Marie Merkowsky

The Ontario Ministry of Long-Term Care has mandated masking for students, support workers, and volunteers when they are in resident areas indoors in long-term facilities

Mask mandates have returned to long-term care facilities in Ontario, as cases increase despite a so-called “safe and effective” jab.

Beginning on November 7, the Ministry of Long-Term Care mandated masks in all licensed long-term care facilities in Ontario, in accordance with the advice of Dr. Kieran Moore, the chief medical officer of health.

“Recent trends have shown a moderate to high level of community transmission of COVID-19 and an increase in COVID-19 outbreaks in LTCHs, with an increased risk of hospitalization amongst residents,” Kelly McAslan, assistant deputy minister, long-term care operations division, said in the memo, obtained by the Canadian Broadcasting Corporation (CBC).

The memo mandates masking for students, support workers, and volunteers when they are in resident areas indoors. Additionally, it recommends that visitors and caregivers mask in resident areas indoors, with the exception of when they are alone with residents in their rooms or when they are eating with residents in shared spaces.

According to Public Health Ontario, from August 27 to October 28, long-term care facilities saw 459 COVID-19 cases among residents, with 181 people hospitalized. A total of 106 residents were reported to have died.

During that time, 1,698 staff members were diagnosed with COVID-19, but there were not deaths or hospitalizations.

The report did not disclose if the residents had been jabbed against COVID, but it is likely that they would have received the experimental shot, as it was mandated in long-term care facilities until March 14, 2022.

Dr. Samir Sinha, director of geriatrics at Sinai Health System in Toronto, promoted the experimental COVID shot for residents in comments to CBC, despite evidence that it provides little to no immunity against COVID.

Sinha also celebrated the mask mandates, ignoring overwhelming evidence that masks are ineffective in preventing transmission of COVID.

The leader of the People’s Party of Canada (PPC) Maxime Bernier, who himself went to jail for fighting COVID mandates, recently warned Canadians to “not comply” with any future dictates should they be enacted again by government officials.

CBC recently admitted that brining back masks would be difficult and likely opposed by many Canadians, suggesting “there would be a revolt” if lockdowns were reinstated.

Since August, many Ontario hospitals have enforced mask mandates, including the Kingston Health Sciences Centre, the Ottawa General Hospital, Ottawa’s Queensway Carleton Hospital, and Perth and Smiths Falls District Hospital.

The mask mandate is being imposed despite overwhelming evidence that masks are not effective in preventing the spread of COVID and can cause a sundry of health issues, as LifeSiteNews has reported.

Among that evidence is the U.S. Centers for Disease Control & Prevention’s (CDC) September 2020 admission that masks cannot be counted on to keep out COVID when spending 15 minutes or longer within six feet of someone, and a May 2020 study published by the peer-reviewed CDC journal Emerging Infectious Diseases that “did not find evidence that surgical-type face masks are effective in reducing laboratory-confirmed influenza transmission, either when worn by infected persons (source control) or by persons in the general community to reduce their susceptibility.”

In May 2021, another study found that, though mandates were largely followed, usage did not yield the expected benefits. “Mask mandates and use (were) not associated with lower SARS-CoV-2 spread among U.S. states” from March 2020 to March 2021. In fact, the researchers found the results to be a net negative, with masks increasing “dehydration … headaches and sweating and decreas[ing] cognitive precision” and interfering with communication, as well as impairing social learning among children.

More than 170 studies have found that masks have been ineffective at stopping COVID and have instead been harmful, especially to children.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

COVID-19

Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’

Published on

From LifeSiteNews

By Conservative Treehouse

The director of National Intelligence revealed gain-of-function ties to US funding, which could indicate that the US helped bankroll the supposed COVID lab leak.

In this segment of a remarkable interview by Megyn Kelly, Director of National Intelligence Tulsi Gabbard discusses the current Intelligence Community (IC) research into the origin of the SARS-CoV-2 pandemic (aka, COVID-19).

Gabbard talks about the U.S. government funding of “gain-of-function” research, which is a soft sounding phrase to describe the weaponization of biological agents.

Gabbard notes the gain-of-function research taking place in the Wuhan lab was coordinated and funded by the United States government, and the IC is close to making a direct link between the research and the release of the COVID-19 virus.

Additionally, Gabbard explains the concern of other biolabs around the world and then gets very close to the line of admitting the IC itself is politically weaponized (which it is but would be stunning to admit).

 

Continue Reading

COVID-19

Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

Published on

From LifeSiteNews

By Nicolas Hulscher, MPH

A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna

A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.

The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:

Study Overview

  • Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
  • Intervention: Two doses of either:
    • BNT162b2 (Pfizer-BioNTech)
    • mRNA-1273 (Moderna)
  • Follow-up Duration: 12 months after second dose.
  • Comparison: Head-to-head between Pfizer vs. Moderna recipients.
  • Main Outcomes:
    • All-cause mortality
    • Cardiovascular mortality
    • COVID-19 mortality
    • Non-COVID-19 mortality

All-cause mortality

Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.

  • Pfizer Risk: 847.2 deaths per 100,000 people
  • Moderna Risk: 617.9 deaths per 100,000 people
  • Risk Difference:
    ➔ +229.2 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.37 (i.e., 37% higher mortality risk with Pfizer)
  • Odds Ratio (Adjusted):
    ➔ 1.384 (95% CI: 1.331–1.439)

Cardiovascular mortality

Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.

  • Pfizer Risk: 248.7 deaths per 100,000 people
  • Moderna Risk: 162.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +86.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.53 (i.e., 53% higher cardiovascular mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.540 (95% CI: 1.431–1.657)

COVID-19 mortality

Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.

  • Pfizer Risk: 55.5 deaths per 100,000 people
  • Moderna Risk: 29.5 deaths per 100,000 people
  • Risk Difference:
    ➔ +26.0 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.88 (i.e., 88% higher COVID-19 mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.882 (95% CI: 1.596–2.220)

Non-COVID-19 mortality

Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.

  • Pfizer Risk: 791.6 deaths per 100,000 people
  • Moderna Risk: 588.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +203.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.35 (i.e., 35% higher non-COVID mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.356 (95% CI: 1.303–1.412)

Biological explanations

The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:

The paper hypothesizes differences between Pfizer and Moderna may be due to:

  • Different lipid nanoparticle compositions
  • Differences in manufacturing, biodistribution, or storage conditions

Final conclusion

Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.

Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.

As the authors conclude:

These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.

Reprinted with permission from Focal Points.

Continue Reading

Trending

X